ClinicalTrials.Veeva

Menu

Efficacy of a Novel Multivitamin-Mineral Supplement in Preventing Vitamin Deficiency in Postoperative Bariatric Patients

Y

Yasoo Health

Status and phase

Completed
Phase 3
Phase 2

Conditions

Bariatric Surgery Candidate

Treatments

Dietary Supplement: AquaVanta Chewable Tablet
Dietary Supplement: Nature Made Calcium Softgels
Dietary Supplement: Flinstones Complete
Dietary Supplement: Twin Labs Iron Caps
Dietary Supplement: Rexall Vitamin B12 Tablet

Study type

Interventional

Funder types

Industry

Identifiers

NCT01475617
AQV-001

Details and patient eligibility

About

Approximately 33% of the US adult population can be classified as obese based on body mass index. This epidemic of obesity has resulted in over 200,000 bariatric surgeries performed every year for the treatment of "clinically severe obesity". Roux-en-Y gastric bypass (RYGB) is the most common bariatric procedure performed in the United States and has both restrictive and malabsorptive components. Despite the success of this procedure in creating long lasting weight loss, vitamin and iron deficiencies are common and can lead to significant morbidity if not appropriately addressed. Despite the American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines that include vitamin and mineral supplementation recommendations, there has been very little prospective research conducted to assess the efficacy and compliance of these micronutrient interventions.

This prospective randomized controlled clinical study will evaluate the efficacy of a novel vitamin/mineral supplement in decreasing micronutrient deficiencies in post operative bariatric patients.

Enrollment

61 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ages 18 - 65 years of age
  • Meet appropriate criteria for Roux-en-Y gastric bypass (RYGB) surgery as determined by the Principal Investigator at The John's Hopkins Center for Bariatric Surgery (JHCBS)

Exclusion criteria

  • Allergy to a component of the formulations
  • Recent (last 3 months) use of a dietary supplement other than a standard non-bariatric specific multivitamin supplement
  • Documented levels of fat-soluble vitamins (A,D,E,K) or iron above the normal range
  • Pregnant or lactating
  • Expected poor compliance with medical regimen as assessed by JHCBS clinic care providers

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

61 participants in 2 patient groups

Novel Multivitamin/Mineral Supplement
Experimental group
Description:
These subjects will be given a novel multivitamin/mineral supplement post RYGB bariatric surgery for 6 months duration.
Treatment:
Dietary Supplement: AquaVanta Chewable Tablet
Dietary Supplement: Nature Made Calcium Softgels
Dietary Supplement: Nature Made Calcium Softgels
Standard of care supplement
Active Comparator group
Description:
These subjects will be given the standard recommended regimen at Johns Hopkins Bayview Medical Center post RYGB bariatric surgery for 6 months duration.
Treatment:
Dietary Supplement: Twin Labs Iron Caps
Dietary Supplement: Rexall Vitamin B12 Tablet
Dietary Supplement: Nature Made Calcium Softgels
Dietary Supplement: Flinstones Complete
Dietary Supplement: Nature Made Calcium Softgels

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems